|
Market Closed -
Nasdaq
16:00:00 2026-11-06 EST
|
5-day change | 1st Jan Change | ||
| 6.930 USD | +4.52% |
|
-3.35% | -61.84% |
| 11-06 | BofA Securities Adjusts Avalo Therapeutics Price target to $24 From $29 | MT |
| 11-05 | Wedbush Adjusts Price Target on Avalo Therapeutics to $20 From $22, Keeps Outperform Rating | MT |
Chart calendar Avalo Therapeutics, Inc.
Upcoming events on Avalo Therapeutics, Inc.
No events available
Past events on Avalo Therapeutics, Inc.
| 2026-06-02 | Annual General Meeting | 08:30 |
| 2026-06-02 | Présentation aux Actionnaires / Analystes | 08:30 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,92 1,70 13.18% | 0,44 0,22 96.44% | 0,06 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -96,9 | -133 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -27,4 -23,1 -18.4% | -68,5 -70,0 2.09% | -72,9 -71,5 -2% | -103 | -132 | -139 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -31,5 -26,8 -17.65% | -35,0 -14,4 -143.99% | -78,1 -80,8 3.34% | -103 | -132 | -137 |
|
Net income Million USD | Released Forecast Spread | -31,5 -26,8 -17.7% | -35,1 -108 67.6% | -78,3 -81,0 3.39% | -101 | -126 | -137 |
|
EPS USD | Released Forecast Spread | -114 -96,0 -18.75% | -7,94 -24,7 67.89% | -5,84 -6,31 7.44% | -2,42 | -2,47 | -2,11 |
| Announcement Date | 29/03/24 | 20/03/25 | 23/03/26 | - |
Quarterly results
| Fiscal Period | September | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,06 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -14,7 -14,4 -1.75% | -19,3 -14,8 -30.38% | -19,2 -18,2 -5.75% | -19,7 -19,7 -0.37% | -20,9 -19,7 -5.85% | -31,5 -21,3 -47.84% | -23,4 -28,5 18.02% | -27,1 | -29,1 | -32,6 | -35,3 | -42,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,1 -15,5 15.11% | -20,7 -15,4 -34.49% | -30,6 -18,8 -63.08% | -13,6 -20,8 34.69% | -19,6 -19,1 -2.78% | -36,3 -20,6 -76.2% | -18,9 -28,5 33.48% | -25,5 | -29,4 | -33,7 | -37,3 | -45,5 |
|
Net income Million USD | Released Forecast Spread | -13,1 -14,9 11.56% | -20,8 -15,2 -36.75% | -30,6 -18,8 -63.31% | -13,7 -20,6 33.32% | -19,6 -19,2 -2.46% | -36,4 -21,0 -73.51% | -18,9 -28,3 33.08% | -24,7 | -27,5 | -31,1 | -34,1 | -40,8 |
|
EPS USD | Released Forecast Spread | -1,25 -1,06 -18.48% | -1,92 -1,40 -37% | -2,19 -1,66 -32.03% | -0,37 -1,47 74.83% | -0,98 -1,03 4.44% | -0,83 -0,60 -38.52% | -0,34 -0,61 44.51% | -0,46 | -0,51 | -0,57 | -0,62 | -0,74 |
| Announcement Date | 12/05/25 | 07/08/25 | 06/11/25 | 23/03/26 | 13/05/26 | 06/08/26 | 05/11/26 | - | - | - | - | - |
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings presentation | 16:30 | |
| Today | Earnings release - Q3 2026 | 16:00 | |
| Today | Earnings presentation | 16:30 | |
| Today | Earnings release - Q3 2026 | ||
| Today | Information meeting | 08:30 | |
| 2026-11-09 | Extraordinary General Meeting | 21:00 | |
| Today | Earnings presentation | 08:30 | |
| Today | Earnings release - Q3 2026 | ||
| 2026-11-10 | Earnings release - Q3 2026 |
Past sector events for Avalo Therapeutics, Inc.
| Today | Earnings presentation | 22:00 | |
| 2026-11-07 | Information meeting | 08:00 | |
| 2026-11-06 | Earnings release - Q3 2026 | 01:00 | |
| 2026-11-05 | Earnings release - Q3 2026 | 11:00 | |
| 2026-11-05 | Earnings presentation | 12:00 | |
| 2026-11-05 | Earnings presentation | 08:00 | |
| 2026-11-05 | Earnings release - Q3 2026 | ||
| 2026-11-05 | Earnings release - Q3 2026 | ||
| 2026-11-05 | Earnings presentation | 16:30 | |
| 2026-11-05 | Earnings presentation | 08:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AVTX Stock
- Calendar Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
















